Exendin-9,39 and Satiety After Bariatric Surgery

NCT02779075 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Saline
DRUG: Exendin-9,39

Sponsor

Mayo Clinic

Collaborators

[object Object]